$ALNY ALNYLAM PHARMACEUTICALS, INC. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in ALNYLAM PHARMACEUTICALS, INC..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in ALNYLAM PHARMACEUTICALS, INC.. Insider overview, share value development, latest insider transactions and email notifications about new events in ALNYLAM PHARMACEUTICALS, INC. for free.

CIK Number: 0001178670
IRS Number: 770602661
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: ALNY
Company Address: 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE 02142
Former name: ALNYLAM PHARMACEUTICALS INC, date of change: 2002-07-24

Alnylam Pharmaceuticals, Inc. is a global commercial-stage biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi therapeutics. Its products include ONPATTRO, GIVLAARI, and OXLUMO. The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phillip Zamore, Paul R. Schimmel, and Phillip A. Sharp on June 14, 2002 and is headquartered in Cambridge, MA.

Market Capitalization: $3.49B
Prev close: $40.46
Average Daily Volume: 1,254,630
Days Low: $39.66
Year Low: $31.38
Year High: $80.11

ALNYLAM PHARMACEUTICALS, INC. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 17 2021ALNYALNYLAM PHARMACEUT ...MARAGANORE JOHNChief Executive Off ...Option ExerciseM7.1033,979241,25167,957
May 17 2021ALNYALNYLAM PHARMACEUT ...MARAGANORE JOHNChief Executive Off ...SellS134.371,023137,461214,765215.8 K to 214.8 K (-0.47 %)
May 17 2021ALNYALNYLAM PHARMACEUT ...MARAGANORE JOHNChief Executive Off ...SellS133.561,624216,901215,788217.4 K to 215.8 K (-0.75 %)
May 17 2021ALNYALNYLAM PHARMACEUT ...MARAGANORE JOHNChief Executive Off ...SellS132.323,481460,606217,412220.9 K to 217.4 K (-1.58 %)
May 17 2021ALNYALNYLAM PHARMACEUT ...MARAGANORE JOHNChief Executive Off ...SellS131.1811,2031,469,610220,893232.1 K to 220.9 K (-4.83 %)
May 17 2021ALNYALNYLAM PHARMACEUT ...MARAGANORE JOHNChief Executive Off ...SellS130.349,1211,188,831232,096241.2 K to 232.1 K (-3.78 %)
May 17 2021ALNYALNYLAM PHARMACEUT ...MARAGANORE JOHNChief Executive Off ...SellS129.324,512583,492241,217245.7 K to 241.2 K (-1.84 %)
May 17 2021ALNYALNYLAM PHARMACEUT ...MARAGANORE JOHNChief Executive Off ...SellS128.303,015386,825245,729248.7 K to 245.7 K (-1.21 %)
May 17 2021ALNYALNYLAM PHARMACEUT ...MARAGANORE JOHNChief Executive Off ...BuyM7.1033,979241,251248,744214.8 K to 248.7 K (+15.82 %)
Apr 21 2021ALNYALNYLAM PHARMACEUT ...Vaishnaw AkshayPresident, R&DSellS138.4810714,81714,11914.2 K to 14.1 K (-0.75 %)
Apr 21 2021ALNYALNYLAM PHARMACEUT ...Vaishnaw AkshayPresident, R&DSellS137.6053072,92814,22614.8 K to 14.2 K (-3.59 %)
Apr 21 2021ALNYALNYLAM PHARMACEUT ...Vaishnaw AkshayPresident, R&DSellS136.841,892258,90114,75616.6 K to 14.8 K (-11.36 %)
Apr 21 2021ALNYALNYLAM PHARMACEUT ...Vaishnaw AkshayPresident, R&DSellS135.4120327,48816,64816.9 K to 16.6 K (-1.20 %)
Apr 21 2021ALNYALNYLAM PHARMACEUT ...Vaishnaw AkshayPresident, R&DPayment of ExerciseF134.568511,43816,85116.9 K to 16.9 K (-0.50 %)
Apr 21 2021ALNYALNYLAM PHARMACEUT ...Vaishnaw AkshayPresident, R&DPayment of ExerciseF131.752,266298,54616,93619.2 K to 16.9 K (-11.80 %)

View all ALNYLAM PHARMACEUTICALS, INC. insider transactions.